Quest Diagnostics Incorporated (LON: 0KSX)

Market Cap	13.73B
Revenue (ttm)	7.12B
Net Income (ttm)	625.23M
Shares Out	n/a
EPS (ttm)	5.55
PE Ratio	21.96
Forward PE	n/a
Dividend	2.37 (1.57%)
Ex-Dividend Date	Jan 14, 2025

Volume	275
Average Volume	208
Open	150.84
Previous Close	151.15
Day's Range	150.73 - 152.01
52-Week Range	119.84 - 152.01
Beta	0.89
RSI	48.68
Earnings Date	Jan 31, 2025

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, govern...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1967
• Employees: 48,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KSX

Financial Performance

In 2023, Quest Diagnostics's revenue was $9.25 billion, a decrease of -6.38% compared to the previous year's $9.88 billion. Earnings were $850.00 million, a decrease of -9.77%.

Financial numbers in USD